Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Operating Expenses | 75,918 | 60,423 | 39,163 | 30,208 | 21,833 |
| Operating Income | -75,918 | -60,423 | -39,163 | -30,208 | -21,833 |
| Interest Expense | 62 | 49 | 27 | 33 | 39 |
| Other Income | 24,967 | 22,361 | 15,834 | 15,946 | 3,242 |
| Pre-tax Income | -51,013 | -38,110 | -23,356 | -14,294 | -18,630 |
| Net Income Continuous | -51,013 | -38,110 | -23,356 | -14,294 | -18,630 |
| Minority Interests | 708 | 385 | 567 | 431 | 862 |
| Net Income | $-50,305 | $-37,725 | $-22,789 | $-13,863 | $-17,768 |
| EPS Basic Total Ops | -0.10 | -0.09 | -0.07 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | -0.10 | -0.09 | -0.07 | -0.04 | -0.05 |
| EPS Diluted Total Ops | -0.10 | -0.09 | -0.07 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | -0.10 | -0.09 | -0.07 | -0.04 | -0.05 |
| EBITDA(a) | $-50,351 | $-37,460 | $-22,778 | $-13,422 | $-17,969 |